{"id": "article-30345_0", "title": "Lithium Toxicity -- Continuing Education Activity", "content": "Lithium, a monovalent cation similar to sodium with an unknown mechanism, was first approved by the U.S. Food and Drug Administration (FDA) as a mood-stabilizing medication for the treatment of mania in the 1970s. Lithium is a very powerful, antimanic medication with a narrow therapeutic index. This activity reviews the indications, mode of action, the toxicity of lithium and highlights the role of the interprofessional team in the management of patients with drug toxicity.", "contents": "Lithium Toxicity -- Continuing Education Activity. Lithium, a monovalent cation similar to sodium with an unknown mechanism, was first approved by the U.S. Food and Drug Administration (FDA) as a mood-stabilizing medication for the treatment of mania in the 1970s. Lithium is a very powerful, antimanic medication with a narrow therapeutic index. This activity reviews the indications, mode of action, the toxicity of lithium and highlights the role of the interprofessional team in the management of patients with drug toxicity."}
{"id": "article-30345_1", "title": "Lithium Toxicity -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of lithium toxicity. Review lithium toxicokinetics. Summarize the treatment of lithium toxicity. Outline interprofessional team strategies for improving care coordination and communication to advance care bundle approaches to manage lithium toxicity and improve patient outcomes. Access free multiple choice questions on this topic.", "contents": "Lithium Toxicity -- Continuing Education Activity. Objectives: Describe the pathophysiology of lithium toxicity. Review lithium toxicokinetics. Summarize the treatment of lithium toxicity. Outline interprofessional team strategies for improving care coordination and communication to advance care bundle approaches to manage lithium toxicity and improve patient outcomes. Access free multiple choice questions on this topic."}
{"id": "article-30345_2", "title": "Lithium Toxicity -- Introduction", "content": "The drug of choice for recurrent bipolar illness management remains to be lithium [1] .\u00a0Lithium, a monovalent cation similar to sodium with an unknown mechanism,\u00a0was first approved\u00a0by the U.S. Food and Drug Administration (FDA)\u00a0as a mood-stabilizing medication\u00a0for the treatment of mania\u00a0in the 1970s [2] . Lithium is a very\u00a0powerful, antimanic medication with a narrow therapeutic index [3] . Pharmacodynamics Lithium's physiologic role is unknown, and its mechanism is not well understood; however, some proposed mechanisms include: Producing brain inositol depletion, leading to reduced responsiveness to alpha-adrenergic stimulation [4] . Reducing neuronal responsiveness to neurotransmitters due to inhibitory effects on adenylate cyclase and G proteins vital for ion channel opening [5] . Stimulating serotonin release from the\u00a0hippocampus [6] . Being a cation, acting similar\u00a0to potassium and sodium, thus affecting ion transport and cell membrane potential [7] .", "contents": "Lithium Toxicity -- Introduction. The drug of choice for recurrent bipolar illness management remains to be lithium [1] .\u00a0Lithium, a monovalent cation similar to sodium with an unknown mechanism,\u00a0was first approved\u00a0by the U.S. Food and Drug Administration (FDA)\u00a0as a mood-stabilizing medication\u00a0for the treatment of mania\u00a0in the 1970s [2] . Lithium is a very\u00a0powerful, antimanic medication with a narrow therapeutic index [3] . Pharmacodynamics Lithium's physiologic role is unknown, and its mechanism is not well understood; however, some proposed mechanisms include: Producing brain inositol depletion, leading to reduced responsiveness to alpha-adrenergic stimulation [4] . Reducing neuronal responsiveness to neurotransmitters due to inhibitory effects on adenylate cyclase and G proteins vital for ion channel opening [5] . Stimulating serotonin release from the\u00a0hippocampus [6] . Being a cation, acting similar\u00a0to potassium and sodium, thus affecting ion transport and cell membrane potential [7] ."}
{"id": "article-30345_3", "title": "Lithium Toxicity -- Etiology", "content": "Too much lithium can cause lithium toxicity. Factors increasing lithium concentration in the body include excessive intake and impaired excretion [8] .", "contents": "Lithium Toxicity -- Etiology. Too much lithium can cause lithium toxicity. Factors increasing lithium concentration in the body include excessive intake and impaired excretion [8] ."}
{"id": "article-30345_4", "title": "Lithium Toxicity -- Epidemiology", "content": "A study evaluated a group of patients treated with lithium between 1997 and 2013 and the recurrence of lithium intoxication along with changes in renal functionality was to be assessed. 96 patients out of 1340 experienced at least one episode of lithium levels greater than 1.5 mmol/L. a cohort of seventy-seven participants had experienced 91 episodes, of whom 34% needed intensive care and 13% required hemodialysis with no deaths. Acute kidney injury occurred, but renal function at baseline was not different from renal function after the episode [9] .", "contents": "Lithium Toxicity -- Epidemiology. A study evaluated a group of patients treated with lithium between 1997 and 2013 and the recurrence of lithium intoxication along with changes in renal functionality was to be assessed. 96 patients out of 1340 experienced at least one episode of lithium levels greater than 1.5 mmol/L. a cohort of seventy-seven participants had experienced 91 episodes, of whom 34% needed intensive care and 13% required hemodialysis with no deaths. Acute kidney injury occurred, but renal function at baseline was not different from renal function after the episode [9] ."}
{"id": "article-30345_5", "title": "Lithium Toxicity -- Pathophysiology", "content": "Excessive intake or impaired excretion can result in lithium accumulation.", "contents": "Lithium Toxicity -- Pathophysiology. Excessive intake or impaired excretion can result in lithium accumulation."}
{"id": "article-30345_6", "title": "Lithium Toxicity -- Pathophysiology -- Excessive Intake", "content": "Suicidal intent or accidental ingestion of excessive amounts of lithium tablets\u00a0result in acute or acute-on-chronic overdose settings [10] . Moreover, excessive intake might arise from dose modifications for the patient chronically administering lithium [11] .", "contents": "Lithium Toxicity -- Pathophysiology -- Excessive Intake. Suicidal intent or accidental ingestion of excessive amounts of lithium tablets\u00a0result in acute or acute-on-chronic overdose settings [10] . Moreover, excessive intake might arise from dose modifications for the patient chronically administering lithium [11] ."}
{"id": "article-30345_7", "title": "Lithium Toxicity -- Pathophysiology -- Impaired Excretion", "content": "Several factors might lead to impairment in lithium secretion. Sodium and volume depletion due to any conditions like vomiting, diarrhea, febrile illness, renal insufficiency, excessive exercise, water restriction, excessive sweating, low sodium diet, and congestive heart failure may enhance lithium reabsorption in the kidneys [11] . Furthermore, drugs reducing the glomerular filtration rate might inflict chronic toxicity.", "contents": "Lithium Toxicity -- Pathophysiology -- Impaired Excretion. Several factors might lead to impairment in lithium secretion. Sodium and volume depletion due to any conditions like vomiting, diarrhea, febrile illness, renal insufficiency, excessive exercise, water restriction, excessive sweating, low sodium diet, and congestive heart failure may enhance lithium reabsorption in the kidneys [11] . Furthermore, drugs reducing the glomerular filtration rate might inflict chronic toxicity."}
{"id": "article-30345_8", "title": "Lithium Toxicity -- Pathophysiology -- Impaired Excretion", "content": "Chronic therapy with lithium can precipitate nephrogenic diabetes insipidus, which might elicit a cascade of symptoms and signs of lithium toxicity. This can be attributed to the diminished urinary concentrating capacity of the kidneys [12] . Noteworthy, a vicious cycle of lithium toxicity might result from the concomitant existence of intercurrent illness with the reduced kidney concentrating capacity precipitated by lithium. For example, reduced clearance and excretion of lithium in case of sodium and volume depletion will result in increased lithium concentration in the serum, which in turn\u00a0continues to affect the kidneys\u2019 ability to concentrate urine negatively.", "contents": "Lithium Toxicity -- Pathophysiology -- Impaired Excretion. Chronic therapy with lithium can precipitate nephrogenic diabetes insipidus, which might elicit a cascade of symptoms and signs of lithium toxicity. This can be attributed to the diminished urinary concentrating capacity of the kidneys [12] . Noteworthy, a vicious cycle of lithium toxicity might result from the concomitant existence of intercurrent illness with the reduced kidney concentrating capacity precipitated by lithium. For example, reduced clearance and excretion of lithium in case of sodium and volume depletion will result in increased lithium concentration in the serum, which in turn\u00a0continues to affect the kidneys\u2019 ability to concentrate urine negatively."}
{"id": "article-30345_9", "title": "Lithium Toxicity -- Toxicokinetics", "content": "Different types of\u00a0lithium formulations are present including\u00a0sustained-release preparations [3] .", "contents": "Lithium Toxicity -- Toxicokinetics. Different types of\u00a0lithium formulations are present including\u00a0sustained-release preparations [3] ."}
{"id": "article-30345_10", "title": "Lithium Toxicity -- Toxicokinetics", "content": "Lithium is neither metabolized nor protein-bound, thus its bioavailability usually is close to 100%. Moreover, lithium absorption is rapid [3] .", "contents": "Lithium Toxicity -- Toxicokinetics. Lithium is neither metabolized nor protein-bound, thus its bioavailability usually is close to 100%. Moreover, lithium absorption is rapid [3] ."}
{"id": "article-30345_11", "title": "Lithium Toxicity -- Toxicokinetics", "content": "Serum lithium levels reflect only the extracellular lithium concentration. However, lithium exerts its effects once it has moved to its intracellular compartment. This phenomenon illustrates the reason why\u00a0patients with significantly\u00a0elevated serum levels might be asymptomatic [12] .", "contents": "Lithium Toxicity -- Toxicokinetics. Serum lithium levels reflect only the extracellular lithium concentration. However, lithium exerts its effects once it has moved to its intracellular compartment. This phenomenon illustrates the reason why\u00a0patients with significantly\u00a0elevated serum levels might be asymptomatic [12] ."}
{"id": "article-30345_12", "title": "Lithium Toxicity -- Toxicokinetics", "content": "Lithium is more susceptible to accumulation in the liver, bone, muscle, or thyroid\u00a0with brain and kidney showing the highest levels [13] .", "contents": "Lithium Toxicity -- Toxicokinetics. Lithium is more susceptible to accumulation in the liver, bone, muscle, or thyroid\u00a0with brain and kidney showing the highest levels [13] ."}
{"id": "article-30345_13", "title": "Lithium Toxicity -- Toxicokinetics", "content": "The kidneys are responsible for 95% of lithium excretion, and the rest is removed through sweat and feces. The kidneys treat lithium and sodium similarly which is the reason sodium depletion can significantly elevate lithium reabsorption [14] .", "contents": "Lithium Toxicity -- Toxicokinetics. The kidneys are responsible for 95% of lithium excretion, and the rest is removed through sweat and feces. The kidneys treat lithium and sodium similarly which is the reason sodium depletion can significantly elevate lithium reabsorption [14] ."}
{"id": "article-30345_14", "title": "Lithium Toxicity -- Toxicokinetics", "content": "Volume depletion from diuretics, dehydration, febrile illness, or gastrointestinal loss can lead to elevated lithium levels in the serum [9] .", "contents": "Lithium Toxicity -- Toxicokinetics. Volume depletion from diuretics, dehydration, febrile illness, or gastrointestinal loss can lead to elevated lithium levels in the serum [9] ."}
{"id": "article-30345_15", "title": "Lithium Toxicity -- Toxicokinetics", "content": "The serum elimination half-life of lithium can vary from 12 to 27 hours. In patients with chronic intoxication, the half-life can be prolonged up to 48 hours [15] .", "contents": "Lithium Toxicity -- Toxicokinetics. The serum elimination half-life of lithium can vary from 12 to 27 hours. In patients with chronic intoxication, the half-life can be prolonged up to 48 hours [15] ."}
{"id": "article-30345_16", "title": "Lithium Toxicity -- Toxicokinetics", "content": "The renal clearance of lithium is usually 10 to 40 mL/ min. However, the clearance may be decreased to 15 mL/min, and the elimination half-life can be as long as 58 hours in elder patients [16] .", "contents": "Lithium Toxicity -- Toxicokinetics. The renal clearance of lithium is usually 10 to 40 mL/ min. However, the clearance may be decreased to 15 mL/min, and the elimination half-life can be as long as 58 hours in elder patients [16] ."}
{"id": "article-30345_17", "title": "Lithium Toxicity -- Toxicokinetics", "content": "Lithium freely crosses the placenta and is also excreted in breast milk. It is labeled as pregnancy class D and has been implicated in the increased risk of congenital cardiac defects, particularly the Ebstein anomaly. Breastfeeding infants of mothers taking lithium have been reported to have signs of cyanosis, hypotonia, and lethargy [14] .", "contents": "Lithium Toxicity -- Toxicokinetics. Lithium freely crosses the placenta and is also excreted in breast milk. It is labeled as pregnancy class D and has been implicated in the increased risk of congenital cardiac defects, particularly the Ebstein anomaly. Breastfeeding infants of mothers taking lithium have been reported to have signs of cyanosis, hypotonia, and lethargy [14] ."}
{"id": "article-30345_18", "title": "Lithium Toxicity -- History and Physical -- History", "content": "In the late 1800s, lithia\u00a0water was first introduced as a mania and gout treatment [17] . Afterward, lithium tablets with higher lithium concentration largely replaced lithia water. However, the higher lithium concentration found in the tablets was associated with tremors and weakness, and in 1898 lithium toxicity was first described. To determine the extent of lithium toxicity, one must determine the ingested amount, time of ingestion, whether there are co-ingestants, and if the ingestion\u00a0was intentional or unintentional. It is worth noting that lithium toxicity signs do not often conform to the measured lithium level [18] .", "contents": "Lithium Toxicity -- History and Physical -- History. In the late 1800s, lithia\u00a0water was first introduced as a mania and gout treatment [17] . Afterward, lithium tablets with higher lithium concentration largely replaced lithia water. However, the higher lithium concentration found in the tablets was associated with tremors and weakness, and in 1898 lithium toxicity was first described. To determine the extent of lithium toxicity, one must determine the ingested amount, time of ingestion, whether there are co-ingestants, and if the ingestion\u00a0was intentional or unintentional. It is worth noting that lithium toxicity signs do not often conform to the measured lithium level [18] ."}
{"id": "article-30345_19", "title": "Lithium Toxicity -- History and Physical -- Neurologic Effects", "content": "Symptoms\u00a0of intoxication include coarse tremor, hyperreflexia, nystagmus, and ataxia. Patients often show varying consciousness levels, ranging from mild confusion to delirium. Although the neurological symptoms are mostly reversible, some reports indicate that symptoms might persist for 12 months never resolve [9] .", "contents": "Lithium Toxicity -- History and Physical -- Neurologic Effects. Symptoms\u00a0of intoxication include coarse tremor, hyperreflexia, nystagmus, and ataxia. Patients often show varying consciousness levels, ranging from mild confusion to delirium. Although the neurological symptoms are mostly reversible, some reports indicate that symptoms might persist for 12 months never resolve [9] ."}
{"id": "article-30345_20", "title": "Lithium Toxicity -- History and Physical -- Renal Toxicity", "content": "Renal toxicity is more common\u00a0in patients on chronic lithium treatment. Toxicity includes impaired urinary concentrating ability, nephrogenic diabetes insipidus (the most common cause of drug-induced NDI), sodium-losing nephritis, nephrotic syndrome along with other manifestations is prescribed [19] .", "contents": "Lithium Toxicity -- History and Physical -- Renal Toxicity. Renal toxicity is more common\u00a0in patients on chronic lithium treatment. Toxicity includes impaired urinary concentrating ability, nephrogenic diabetes insipidus (the most common cause of drug-induced NDI), sodium-losing nephritis, nephrotic syndrome along with other manifestations is prescribed [19] ."}
{"id": "article-30345_21", "title": "Lithium Toxicity -- History and Physical -- Cardiovascular Effects", "content": "These are usually mild and non-specific. Almost all patients treated with lithium will develop T wave flattening. Sinus node dysfunction is the most common reported conduction defect followed by QT prolongation, intraventricular conduction defects, and U waves. These findings are reversible [20] .", "contents": "Lithium Toxicity -- History and Physical -- Cardiovascular Effects. These are usually mild and non-specific. Almost all patients treated with lithium will develop T wave flattening. Sinus node dysfunction is the most common reported conduction defect followed by QT prolongation, intraventricular conduction defects, and U waves. These findings are reversible [20] ."}
{"id": "article-30345_22", "title": "Lithium Toxicity -- History and Physical -- Gastrointestinal Effects", "content": "Symptoms typically occur within 1 hour of ingestion and are more common in the acute overdose setting [15] .", "contents": "Lithium Toxicity -- History and Physical -- Gastrointestinal Effects. Symptoms typically occur within 1 hour of ingestion and are more common in the acute overdose setting [15] ."}
{"id": "article-30345_23", "title": "Lithium Toxicity -- History and Physical -- Endocrine Effects", "content": "Lithium administration leads to the inhibition of thyroid hormone synthesis and subsequent release, resulting in hypothyroidism. Hyperthyroidism is less commonly manifested, which can mask symptoms of lithium toxicity and boost its toxicity by prompting cellular unresponsiveness and altered renal tubular handling of lithium [21] .", "contents": "Lithium Toxicity -- History and Physical -- Endocrine Effects. Lithium administration leads to the inhibition of thyroid hormone synthesis and subsequent release, resulting in hypothyroidism. Hyperthyroidism is less commonly manifested, which can mask symptoms of lithium toxicity and boost its toxicity by prompting cellular unresponsiveness and altered renal tubular handling of lithium [21] ."}
{"id": "article-30345_24", "title": "Lithium Toxicity -- Evaluation", "content": "Initially, the studies should include cardiac monitoring, electrocardiogram, assessment of oxygenation and monitoring of urine output, serum electrolytes, calcium, renal function, glucose, serum lithium level, and thyroid-stimulating hormone [22] . Moreover, both therapeutic lithium usage and intoxication can be accompanied by leukocytosis. Furthermore, interference by the carbonate anion after lithium carbonate acute ingestion in the calculation of anion gap might lead to a low anion gap [23] . Patients are susceptible to renal insufficiency with elevated blood urea nitrogen and creatinine in case of chronic intoxication [24] . If the initial diagnosis is unclear, brain imaging may be required [25] . Lithium serum levels normally range from approximately 0.6 to 1.2 mEq/L. Measurement of the serum levels should be carried out at least 6 to 12 hours after the last therapeutic dose to avoid misinterpretation of pre-distributional levels.", "contents": "Lithium Toxicity -- Evaluation. Initially, the studies should include cardiac monitoring, electrocardiogram, assessment of oxygenation and monitoring of urine output, serum electrolytes, calcium, renal function, glucose, serum lithium level, and thyroid-stimulating hormone [22] . Moreover, both therapeutic lithium usage and intoxication can be accompanied by leukocytosis. Furthermore, interference by the carbonate anion after lithium carbonate acute ingestion in the calculation of anion gap might lead to a low anion gap [23] . Patients are susceptible to renal insufficiency with elevated blood urea nitrogen and creatinine in case of chronic intoxication [24] . If the initial diagnosis is unclear, brain imaging may be required [25] . Lithium serum levels normally range from approximately 0.6 to 1.2 mEq/L. Measurement of the serum levels should be carried out at least 6 to 12 hours after the last therapeutic dose to avoid misinterpretation of pre-distributional levels."}
{"id": "article-30345_25", "title": "Lithium Toxicity -- Evaluation", "content": "Of note, lithium heparin is used as an anticoagulant in some specimen tubes which can falsely increase results of serum lithium [26] .", "contents": "Lithium Toxicity -- Evaluation. Of note, lithium heparin is used as an anticoagulant in some specimen tubes which can falsely increase results of serum lithium [26] ."}
{"id": "article-30345_26", "title": "Lithium Toxicity -- Treatment / Management -- Decontamination", "content": "In-vitro studies showed that lithium does not adhere effectively to activated charcoal [27] ; however, if co-ingestants are unknown, charcoal should be administered [8] . Gastric lavage should be considered, particularly in the case of regular-release preparations and patients presenting early to the emergency department. On the other hand, in case of sustained-release preparations, administration, or massive ingestion of regular-release products, whole-bowel irrigation should also be considered [8] .", "contents": "Lithium Toxicity -- Treatment / Management -- Decontamination. In-vitro studies showed that lithium does not adhere effectively to activated charcoal [27] ; however, if co-ingestants are unknown, charcoal should be administered [8] . Gastric lavage should be considered, particularly in the case of regular-release preparations and patients presenting early to the emergency department. On the other hand, in case of sustained-release preparations, administration, or massive ingestion of regular-release products, whole-bowel irrigation should also be considered [8] ."}
{"id": "article-30345_27", "title": "Lithium Toxicity -- Treatment / Management -- Elimination", "content": "The most appropriate method of lithium removal is hemodialysis,\u00a0particularly if the patient demonstrates signs and symptoms of severe lithium poisoning or is having a renal failure due to its small volume of distribution and marginal protein binding [28] . Peritoneal dialysis should not replace hemodialysis; however, if the hemodialysis facilities are not available (e.g., in remote areas), peritoneal dialysis can be initiated [28] .", "contents": "Lithium Toxicity -- Treatment / Management -- Elimination. The most appropriate method of lithium removal is hemodialysis,\u00a0particularly if the patient demonstrates signs and symptoms of severe lithium poisoning or is having a renal failure due to its small volume of distribution and marginal protein binding [28] . Peritoneal dialysis should not replace hemodialysis; however, if the hemodialysis facilities are not available (e.g., in remote areas), peritoneal dialysis can be initiated [28] ."}
{"id": "article-30345_28", "title": "Lithium Toxicity -- Treatment / Management -- Disposition", "content": "All patients with toxicity signs and symptoms, even those with normal serum lithium levels, should be admitted for monitoring in the hospital. In case of moderate or severe symptoms, the patient has to be admitted to an intensive care unit. Serial levels of lithium in the serum should be obtained every 6 hours in case of asymptomatic patients after acute ingestion. This should be continued until a descending drift has been established. Patients should not be discharged until they are asymptomatic and have a serum lithium level less than 1.5 mEq/L.", "contents": "Lithium Toxicity -- Treatment / Management -- Disposition. All patients with toxicity signs and symptoms, even those with normal serum lithium levels, should be admitted for monitoring in the hospital. In case of moderate or severe symptoms, the patient has to be admitted to an intensive care unit. Serial levels of lithium in the serum should be obtained every 6 hours in case of asymptomatic patients after acute ingestion. This should be continued until a descending drift has been established. Patients should not be discharged until they are asymptomatic and have a serum lithium level less than 1.5 mEq/L."}
{"id": "article-30345_29", "title": "Lithium Toxicity -- Differential Diagnosis", "content": "Acute hypoglycemia Alcohol toxicity Anticholinergic toxicity Delirium Dementia Depression Heavy metal toxicity Mercury toxicity Neuroleptic agent toxicity Stroke, ischemic", "contents": "Lithium Toxicity -- Differential Diagnosis. Acute hypoglycemia Alcohol toxicity Anticholinergic toxicity Delirium Dementia Depression Heavy metal toxicity Mercury toxicity Neuroleptic agent toxicity Stroke, ischemic"}
{"id": "article-30345_30", "title": "Lithium Toxicity -- Staging", "content": "Lithium toxicity can be classified into three major categories: Acute overdose in a lithium-naive patient [9] . Acute overdose in a patient on chronic therapy (acute-on-chronic) [29] . Chronic over-medication or drug accumulation (associated with the most serious toxicity) [30] .", "contents": "Lithium Toxicity -- Staging. Lithium toxicity can be classified into three major categories: Acute overdose in a lithium-naive patient [9] . Acute overdose in a patient on chronic therapy (acute-on-chronic) [29] . Chronic over-medication or drug accumulation (associated with the most serious toxicity) [30] ."}
{"id": "article-30345_31", "title": "Lithium Toxicity -- Prognosis", "content": "Lithium toxicity signs are obvious and can be identified and managed easily;\u00a0however, ignoring it can be fatal. Indeed,\u00a0in some cases,\u00a0lithium toxicity can lead to coma, brain damage, or even death. Moreover, lithium can induce serotonin syndrome,\u00a0a potentially fatal and life-threatening condition [31] . The use of serotonergic drugs or drugs inhibiting serotonin metabolism concomitantly with lithium will increase the risk of lithium precipitating serotonin syndrome [32] .", "contents": "Lithium Toxicity -- Prognosis. Lithium toxicity signs are obvious and can be identified and managed easily;\u00a0however, ignoring it can be fatal. Indeed,\u00a0in some cases,\u00a0lithium toxicity can lead to coma, brain damage, or even death. Moreover, lithium can induce serotonin syndrome,\u00a0a potentially fatal and life-threatening condition [31] . The use of serotonergic drugs or drugs inhibiting serotonin metabolism concomitantly with lithium will increase the risk of lithium precipitating serotonin syndrome [32] ."}
{"id": "article-30345_32", "title": "Lithium Toxicity -- Complications", "content": "Intoxication degree is of utmost importance for understanding lithium toxicity diagnosis and management. The severity of lithium toxicity is often divided into the following three grades: mild, moderate, and severe. Mild symptoms : nausea, vomiting, lethargy, tremor, and fatigue (Serum lithium concentration between 1.5-2.5 mEq/L) [33] [34] . Moderate intoxication: confusion, agitation, delirium, tachycardia, and hypertonia (serum lithium\u00a0concentration between\u00a02.5-3.5 mEq/L) [33] [34] . Severe intoxication : Coma, seizures, hyperthermia, and hypotension (serum lithium\u00a0concentration (more than 3.5 mEq/L) [33] [34] .", "contents": "Lithium Toxicity -- Complications. Intoxication degree is of utmost importance for understanding lithium toxicity diagnosis and management. The severity of lithium toxicity is often divided into the following three grades: mild, moderate, and severe. Mild symptoms : nausea, vomiting, lethargy, tremor, and fatigue (Serum lithium concentration between 1.5-2.5 mEq/L) [33] [34] . Moderate intoxication: confusion, agitation, delirium, tachycardia, and hypertonia (serum lithium\u00a0concentration between\u00a02.5-3.5 mEq/L) [33] [34] . Severe intoxication : Coma, seizures, hyperthermia, and hypotension (serum lithium\u00a0concentration (more than 3.5 mEq/L) [33] [34] ."}
{"id": "article-30345_33", "title": "Lithium Toxicity -- Enhancing Healthcare Team Outcomes", "content": "During lithium treatment, the healthcare team including physicians and nurses should make sure serum levels are checked regularly to make sure of the treatment course. Lithium is classified as pregnancy category D which means that there is positive evidence of human fetal risk. Therefore, the nurses or clinician\u00a0should educate the patient on a proper contraceptive method during treatment with lithium. If any signs of early toxicity appear, the patient should stop the medication and seek medical counsel. Extra care should be taken if any activity, illness, or medication might precipitate a profound loss of water and/or salt is taken in a patient administering lithium. [Level 5]", "contents": "Lithium Toxicity -- Enhancing Healthcare Team Outcomes. During lithium treatment, the healthcare team including physicians and nurses should make sure serum levels are checked regularly to make sure of the treatment course. Lithium is classified as pregnancy category D which means that there is positive evidence of human fetal risk. Therefore, the nurses or clinician\u00a0should educate the patient on a proper contraceptive method during treatment with lithium. If any signs of early toxicity appear, the patient should stop the medication and seek medical counsel. Extra care should be taken if any activity, illness, or medication might precipitate a profound loss of water and/or salt is taken in a patient administering lithium. [Level 5]"}
{"id": "article-30345_34", "title": "Lithium Toxicity -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Lithium Toxicity -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}